{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-020817","form_type":"8-K","ticker":"BIXT","cik":"0001445815","company_name":"BIOXYTRAN, INC","filed_at":"2022-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.796807+00:00","generated_at":"2026-06-24T06:25:57.942542+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Bioxytran publishes positive peer-reviewed data for ProLectin-M and PLG-007 drug candidates","bullets":["August 1, 2022 article in Int. J. Health Sciences: ProLectin-M blocks SARS-CoV-2 in vitro; all 5 COVID-19 patients achieved complete remission, zero hospitalization.","July 13, 2022 article in Int. J. Molecular Science: PLG-007 component GMα competitively inhibits α-amylase, maltase, and lactase with Ki of 2.1×10^-6M.","Press release issued August 1, 2022 announcing the ProLectin-M peer-reviewed article and supporting mechanism of action data."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-020817","json":"https://secwatch.observer/filing/0001493152-22-020817.json","markdown":"https://secwatch.observer/filing/0001493152-22-020817.md","text":"https://secwatch.observer/filing/0001493152-22-020817.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1445815/000149315222020817/0001493152-22-020817-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1445815/000149315222020817/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T06:25:57.942542+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}